BSEMinimalNeutral
Announced Mon, 14 Apr · 17:32 IST

Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

J.B. Chemicals & Pharmaceuticals has submitted a certificate to BSE under SEBI Regulation 74(5) from its Registrar and Share Transfer Agent, Datamatics Business Solutions Limited, for the quarter ended March 31, 2025. The certificate confirms that all physical share certificates received for dematerialization during the quarter were properly mutilated and cancelled, and the name of the respective depository was substituted as the registered owner within the 15-day timeline prescribed by SEBI. The filing was signed by the company's Vice President – Secretarial & Company Secretary, Sandeep Phadnis. This is a routine, recurring compliance submission that every listed company must file with the exchange every quarter.

Likely market impact

No material impact on shareholders or stock price — this is a standard procedural filing confirming that the RTA handled share dematerialization requests correctly. Investors can take it as a routine housekeeping confirmation rather than any newsworthy corporate development.